George W. LeMaitre - Dec 11, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Chairman and CEO, Director, 10%+ Owner
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol: LMAT
Transactions as of: Dec 11, 2022
Transactions value $: -$19,450
Form type: 4
Date filed: 12/13/2022, 04:34 PM
Previous filing: Dec 6, 2022
Next filing: Dec 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$0	+12	+0%	$0.00	2.49M	Dec 11, 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	-$19.4K	-419	-0.02%	$46.42	2.49M	Dec 11, 2022	Direct	F2
transaction	LMAT	Common Stock	Award	$0	+5.83K	+0.23%	$0.00	2.5M	Dec 12, 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-12	-20.33%	$0.00	47	Dec 11, 2022	Common Stock	12		Direct	F4
transaction	LMAT	Stock Option (Right to Buy)	Award	$0	+30.4K		$0.00	30.4K	Dec 12, 2022	Common Stock	30.4K	$47.19	Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3	Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F4	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5	The exercise price of this option to the extent it is an incentive stock option is $51.91 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $47.19 per share.
F6	This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
F7	The expiration date of this option to the extent it is an incentive stock option is 12/12/2027, and the expiration date of this option to the extent it is a nonqualified stock option is 12/12/2029.